Objective: To investigate the relationships between endothelial nitric oxide synthases (eNOS) G894T and 27 bpvariable number tandem repeat (VNTR) gene polymorphisms and osteoporosis in the postmenopausal women of Chinese Han nationality. Methods: In the present study, 281 postmenopausal women from Xi'an urban area in West China were recruited, and divided into osteoporosis, osteopenia, and normal groups according to the diagnostic criteria of osteoporosis proposed by World Health Organization (WHO). The bone mineral density (BMD) values of lumbar vertebrae and left hips were determined by QDR-2000 dual energy X-ray absorptiometry. Blood samples were tested for plasma biochemical indicators including testosterone, estradiol, calcitonin, osteocalcin, and procollagen type I amino-terminal propeptide by enzyme-linked immunosorbent assay (ELISA), tartrate-resistant acid phosphatase by spectrophotometric method, and the content of nitric oxide by Griess method. Genome DNA was extracted from whole blood, and G894T polymorphism of eNOS gene was analyzed by using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method and 27 bp-VNTR polymorphism of eNOS gene was genotyped by PCR method. Then the relationships between genotypes and biochemical indicators, genotypes and osteoporosis, and haplotypes and osteoporosis were analyzed. Results: The average BMD values of the femoral neck, ward's triangle and lumbar vertebrae 1~4 (L1~L4) in the subjects with T/T genotype in eNOS G894T locus were significantly higher than those in the subjects with G/T and G/G genotypes (P<0.05). The average BMD of the femoral neck in the subjects with a/a genotype of eNOS 27 bp-VNTR locus was evidently higher than that in the subjects with b/b genotype (P<0.05). The plasma testosterone and osteocalcin concentrations in the subjects of eNOS G894T G/T genotype were evidently higher than those in the subjects of other genotypes (P<0.05); the plasma estradiol concentration in the subjects of eNOS 27 bp-VNTR a/a genotype was obviously higher than that in the subjects of b/b genotype (P<0.01). eNOS G/G homozygous frequencies in osteoporosis women, osteopenia women, and normal women were 85.37%, 76.38%, and 83.87%, respectively (P>0.05). 0% osteoporosis woman, 0.79% osteopenia women, and 3.23% normal women were eNOS a/a homozygous (P<0.05). The frequencies of eNOS 27 bp-VNTR a allele were 5.33% in the osteoporosis group, 10.24% in the osteopenia group, and 16.13% in the normal group (P<0.05, odds ratio (OR)=0.29, 95% confidence interval (CI)=0.11~0.77), suggesting that a/a genotype and a allele might have protective effects on osteoporosis. The haplotype analysis showed that G-b was 87.7% (214/244) in the osteoporosis group (P<0.05, OR=2.48, 95% CI=1.18~5.18). G-a was 5.3% (13/244) in the osteoporosis group (P<0.05, OR=0.29, 95% CI=0.11~0.77). G-b was a risk factor for osteoporosis, and G-a a protective factor. Conclusion: eNOS G894T G/T genotype influenced the plasma testosterone and osteocalcin concentrations, and T/T genotype influenced BMD. eNOS 27 bp-VNTR a/a genotype increased plasma estradiol concentration to have a protective effect on osteoporosis.
INTRODUCTION
Osteoporosis is a systemic metabolic bone disease characterized by decrease of bone mass and degeneration of bone microstructure resulting in increasing bone fragility prone to fracture (Lewiecki, 2008) . Osteoporosis occurs to people with low peak-value of bone mass during their body development or to aged people with abnormal maintenance of bone mass (Walker, 2008) . Many factors are involved in the etiology of primary osteoporosis, and it has been widely believed that environmental factors, such as age, nutrition, exercises, and living habits, play important roles in development of osteoporosis (Ilich and Kerstetter, 2000; Prentice, 2004; Manios et al., 2007; Haas and Moore, 2007) . Smith et al.(1973) first proposed that genetic factors participate in gain of bone mass. Afterward, numerous twin and pedigree studies reported that genetic factors are involved in osteoporosis and the secondary fracture of osteoporosis, and that 80% of bone mass variance in human populations is determined by genetic factors (Ongphiphadhanakul, 2007; Williams and Spector, 2006; Pocock et al., 1987) . Osteoporosis has been believed as a multigenetic disorder in which many genes influence bone mass gain and regulation of bone turnover. The candidate genes for osteoporosis include genes for vitamin D receptor, estrogen receptor, androgen receptor, calcitonin receptor, type I collagen, and transforming growth factor (TGF)-β1 (Williams and Spector, 2007; Ralston, 2007) . Mutations or polymorphisms of these genes may increase susceptibility to osteoporosis. It is still uncertain that which specific gene plays a key role in the development of osteoporosis; therefore, more work needs to be done.
Nitric oxide (NO), a signaling molecule synthesized from L-arginine by nitric oxide synthases (NOS), is an important factor in regulating bone metabolism (van't Hof and . The impact of NO on bone metabolism is two-way directional, affecting not only the function of osteoclasts, but also the differentiation and proliferation of osteoblasts (Brennan et al., 2003; van't Hof et al., 2004) . It has been found that NO is related with osteoporosis development in postmenopausal women (Ozgocmen et al., 2007; Rosselli et al., 1995) . During menstrual cycle, blood NO metabolite concentrations correlate with estrogen levels, being higher in the follicular phase than in the secretory phase (Cicinelli et al., 1996) . NO metabolites decrease in postmenopausal women and are increased by estrogen replacement (Rosselli et al., 1995; Wimalawansa, 2008) . NO may modulate anabolic effects of estrogen on bone homeostasis by restraining osteoclast-mediated bone resorption and stimulating osteoblast activity. Accordingly, NO donated by organic nitrates, including nitroglycerin, is thought to protect from bone loss associated with estrogen deficiency (Wimalawansa, 2008) .
At the present, three NOS isozymes, neuronal NOS (nNOS), inducible NOS (iNOS) and endothelial NOS (eNOS), have been found in mammalians (Ricciardolo et al., 2006; Sun et al., 2005) . Studies on NOS gene-deficient mice provided insight on the functional significance and the relative contributions that the different NOS isoforms and NO may exert on skeletal remodeling (Kozak and Kozak, 2003) . eNOS is the predominant constitutive isoform of NOS within bone. Histomorphometric and bone mineral density (BMD) analyses of young adult eNOS gene-deficient mice revealed marked abnormalities in bone volume and formation rate and the reduced BMD that are mainly related to dysfunctional osteoblasts (Aguirre et al., 2001) . Ovariectomized eNOS gene-deficient mice have the bone lose comparable to that observed in wild-type controls but show a blunted anabolic response to high dose of estrogen (Armour et al., 2001) .
Human eNOS gene located at 7q35-36 includes 26 exons and 25 introns with a total length of 21 kb. There is a 27 bp-variable number tandem repeat (VNTR) polymorphism in the 4th intron of eNOS gene, and based on the number of repeats, 2 kinds of alleles are obtained. The allele with 4 repeats is a allele and the allele with 5 repeats is b allele. It is reported in recent years that 27 bp-VNTR polymorphism in eNOS gene locus is related with many kinds of clinic diseases, such as primary hypertension, type 2 diabetes mellitus, cerebral infarction, coronary heart disease, asthma, and other ischemic cardiovascular and cerebrovascular diseases (Benjafield and Morris, 2000; Hoffmann et al., 2005; Matyar et al., 2005; Mearin et al., 2006; Uthra et al., 2007) . G894T polymorphism in exon 7 of eNOS gene as a missense mutation, affects eNOS protein and is related with the spasm of coronary arteries, myocardial infarction, primary hypertension, left ventricular hypertrophy, artherosclerosis, erectile dysfunction, and cerebral infarction (Li et al., 2005; Tang et al., 2008; Lee et al., 2007; Antoniades et al., 2007; Reali et al., 2008) . Recently, an eNOS polymorphism, Glu298Asp, is implicated in osteoporosis. However, it is rarely reported whether the polymorphisms of eNOS 27 bp-VNTR and G894T gene loci are related with bone metabolism and osteoporosis, so it remains very unclear.
In the present study, we examined the polymorphisms of eNOS 27 bp-VNTR and G894T gene loci, the blood contents of sex hormones, and the related biochemical indicators of postmenopausal women from urban areas of Xi'an, China, and analyzed the relationships between the two kinds of polymorphisms of eNOS genes and BMD and biochemical parameters in order to provide help for early diagnosis of the susceptible population and prevention of osteoporosis.
MATERIALS AND METHODS

Subjects
Included in the study were 281 postmenopausal women aged 45 to 65 years, who were Chinese Han nationality. They had lived in Xi'an urban areas more than 10 years, and had been in natural menopause for more than 6 months, with no diseases that might influence bone metabolism, severe chronic diseases that needed long-term therapies, or gynecological diseases that could influence the secretion of female sex hormones, and no hormone drugs intake or osteoporosis treatment 6 months before the investigation. According to a pilot study, the estimated population morbidity rate of osteoporosis was 40% and the relative allowable error was 20% (α=0.05). Therefore, using Epi-Info software, the sample size was 145. But considering the cluster sampling and possible visiting failures, the sample size was amplified to 290 with multistage cluster sampling method (Liu et al., 2008) . Informed consent was obtained from all the subjects and the investigation was conducted in accordance with humane and ethical research principles from our university.
BMD determination
BMD values in lumbar vertebrae and left hips of all subjects were determined by using QDR-2000 dual energy X-ray absorptiometry (DEXA) (Hologic Company, USA), which was controlled by computers with auto-position fixing, auto-detecting, and autodata manipulating (Liu et al., 2002; Mutlu et al., 2007) . The relative error of repeated detection was 0.5%. In practical operation, the subject lay down in the middle of the detecting bed, with the distance of 3 cm between her head and the bed top, her both hands on the sides of the body, and her two legs straightening and separating gently. Through the fan-shaped scanning, the BMD values of 8 special parts, such as lumber vertebrae (L1~L4), femoral neck, ward's triangle, greater trochanter and intertrochanter of femur, were calculated.
The diagnostic criteria of osteoporosis proposed by World Health Organization (WHO) in 1994 were used (Imashuku et al., 2007; Miller, 2006) , in which a loss of bone mass≤1SD was considered as normal, 1SD<loss of bone mass≤2.5SD as osteopenia, and loss of bone mass>2.5SD as osteoporosis. Among the determined 8 parts of a subject, if T-score of any part <-2.5SD, she was diagnosed as osteoporosis, and for all parts, if T-score≥-1.0SD, she was normal, and the rest should be diagnosed as osteopenia.
Biochemical indicators detection
10 ml superficial vein blood was collected from the elbow of the fasting women, added with heparin anticoagulant, and centrifuged at 3000 r/min for 10 min, and then the plasma was isolated and stored at -70 °C for use. Seven biochemical indicators in the plasma samples were tested for testosterone (T), estradiol (E 2 ), calcitonin (CT), osteocalcin (OC), and procollagen type I amino-terminal propeptide (PINP) by enzyme-linked immunosorbent assay (ELISA), tartrate-resistant acid phosphatase (TRAP) by spectrophotometric method, and the content of NO by Griess method (Liu et al., 2009) . The ELISA kits of testosterone, estradiol, and osteocalcin were purchased from Cayman Chemical Company (USA), and the kits of calcitonin and PINP from Shanghai Xitang Bio-Tech Company (China). The TRAP assay kit was purchased from Nanjing Jiancheng Bio-Tech Company (China).
Genomic DNA extraction 0.2 ml anticoagulant blood was used to extract genomic DNA following the instruction in the TIANamp Blood genomic DNA extraction kit (Qiagen Company, USA). 50~200 ng/μl DNA (optical density ratio of 1.6~1.9 at 260/280 nm) was obtained.
Detection of gene polymorphisms
The eNOS gene is composed of 26 exons on chromosome 7q35-36 (Via et al., 2003) , and there is a 27 bp-VNTR polymorphism in the 4th intron (Smith, et al., 2006) . Polymerase chain reaction (PCR) method was used to detect eNOS 27 bp-VNTR gene polymorphism.
The forward primer was 5′-AGGCCCTATGGTAGTGCCTTT-3′ and the reverse primer 5′-TCTCTTAGTGCTGTGGTCAC-3′ (Beijing Aoke Company, China). A 25-μl reaction contained 50~200 ng of genomic DNA, 10 μl of 2.5× Taq buffer, 0.4 μmol/L of each primer, 0.1 U of Taq DNA polymerase (Qagen Company, USA), and 100 μmol/L of each dNTP. PCR mixture was incubated at 95 °C for 5 min, and then run at 95 °C for 1 min, 63 °C for 30 s, and 72 °C for 30 s for 31 cycles, and a final extension of 72 °C for 10 min. The extended products were electrophoresed on 3% (w/v) agarose gels and visualized after ethidium bromide staining under ultraviolet transillumination.
Because of the G on the 894th position of the 7th exon of the eNOS gene mutated to T (G894T), the Asp replaces Glu on the 298th position of the protein.
The genomic DNA was amplified using PCR and digested by restriction enzyme. Then PCR-restriction fragment length polymorphism (RFLP) method was used to detect eNOS G894T gene polymorphism. This region was amplified by PCR using the forward primer 5′-AAGGCACAGGAGACAGTGGATGGA-3′ and the reverse primer 5′-CCCAGTCAATCCC TTTGGTGCT-3′ (Beijing Aoke Company, China). A 25-μl PCR mixture contained 50~200 ng of genomic DNA, 10 μl of 2.5× Taq buffer, 100 μmol/L of each dNTP, 0.4 μmol/L of each primer, and 0.1 U of Taq DNA polymerase. After the first 95 °C for 5 min, the PCR reaction was run at 95 °C for 1 min, 59 °C for 30 s, and 72 °C for 40 s for 30 cycles, and a final extension of 72 °C for 10 min. 12 μl of PCR product was mixed with 5 U of restriction enzyme BanII, 2 μl of 10× restriction enzyme digestion buffer, and 5μl of deionized water, and incubated at 37 °C for 3 h. The digested PCR products were electrophoresed on 2.5% (w/v) agarose gels and visualized after ethidium bromide staining under ultraviolet transillumination.
Finally, we randomly selected 10% of the samples to repeat the detection of eNOS G894T and eNOS 27 bp-VNTR gene polymorphisms, and the results were fully confirmed.
Statistical analysis
For the case-control analysis, chi-squared (χ  2 ) tests were performed to compare genotypes and allele frequencies using the 2002 version of Epi_Info (http://www.cdc.gov/epiinfo/). Values for D′, the normalised linkage disequilibrium statistic, were calculated by 2LD software. Haplotype frequencies were estimated using the program PHASE version 2.2, a software that implements a Bayesian statistical method for reconstructing haplotypes from population genotype data . The distribution of global haplotype frequencies in cases and controls was compared by the Epi_Info program.
RESULTS
Basic information of subjects
Complete BMD values were obtained from 281 subjects, among whom 280 had gene polymorphism results and 244 had plasma biochemical indicator results. According to the diagnostic criteria of osteoporosis proposed by WHO in 1994 (Imashuku et al., 2007; Miller, 2006) , the 281 subjects were divided into normal group, osteopenia group, and osteoporosis group. The incidence of osteoporosis was found to be 43.77% (123/281), the osteopenia rate 45.20% (127/281), and the normal rate 11.03% (31/281). The BMD values in different body positions are listed in Table 1 .
Gene polymorphism detections
The PCR products of eNOS intron 4 27 bp-VNTR polymorphism included a/a genotype with a 393-bp band, b/b genotype with a 420-bp band, and a/b heterozygous genotype with 393-bp and 420-bp bands (Fig.1a) .
The PCR product of G894T polymorphism detection was 248 bp long. As BanII restriction enzyme recognized G, but not T, the digested product of T/T homozygous genotype was a 248-bp band. The G/G homozygous genotype had two bands, 163 bp and 85 bp, and the G/T heterozygous genotype had three bands, 248, 163, and 85 bp (Fig.1b) .
Relationship between gene polymorphism and BMD
The average BMD of the femur neck in T/T genotype women was (0.817±0. (Table 2) .
Relationship between gene polymorphisms and biochemical indicators
The plasma testosterone concentration of G/T genotype was (38.2±4.4) ng/dl, significantly higher than that of G/G genotype ((36.1±5.8) ng/dl) (P<0.05). The plasma osteocalcin of G/T genotype is (6.2±2.0) ng/ml, significantly higher than that of G/G genotype ((5.1±1.9) ng/ml) and that of TT genotype ((4.2±1.9) ng/ml) (P<0.05). The plasma estradiol concentration of a/a genotype was (101.0±18.4) pg/ml, significantly higher than that of b/b genotype ((70.7±18.6) pg/ml) (P<0.01). Therefore, the plasma testosterone and osteocalcin concentrations of G/T genotype significantly increased; the plasma estradiol concentrations of a/a genotype significantly increased (Table 3) .
Relationship between genotypes and allelic frequencies and osteoporosis
The results showed that eNOS G/G homozygotes accounted for 86.06% (105/122) in osteoporosis patients, 76.38% (97/127) in osteopenia women, and 83.87% (26/31) in normal group (P>0.05). The eNOS a/a homozygous was zero in the osteoporosis group, (Tables 4 and 5) .
Relationship between haplotype and osteoporosis
The haplotype analysis showed that G-b accounted for 87.7% (214/244) in the osteoporosis group (P<0.05, OR=2.48, 95% CI=1.18~5.18 ). G-a accounted for 5.3% (13/244) in the osteoporosis group (P<0.05, OR=0.29, 95% CI=0.11~0.77) . The results show that G-b was an osteoporosis risk factor, and G-a a protective factor for osteoporosis (Table 6) . 
DISCUSSION
Human gene polymorphisms are derived from the different copying numbers of repeat sequences in genome, and also come from the variation of a single nucleotide. They are usually divided into three types: restriction fragment length polymorphism (RFLP), the polymorphisms of DNA repeat sequences, and single nucleotide polymorphism (SNP) (Zhang et al., 2005; Blair et al., 2003; Malone et al., 2008) . In recent years, the research of the relationship between the gene polymorphisms and the susceptibility to diseases has drawn more and more attentions, providing meaningful references for clinical diagnosis, treatment, and prognosis (Shah, 2007; Yang et al., 2008) . It has been reported that polymorphisms are associated with osteoporosis (Williams and Spector, 2006; Pocock et al., 1987; Ralston, 2007) . Strong associations between the risk of osteoporosis and specific polymorphisms of the VDR, ESR1 and COL1A1 genes have been reported (Williams and Spector, 2006; Pocock et al., 1987; Ralston, 2007) . However, the relationship between the polymorphism of eNOS gene and osteoporosis has just recently been studied, remaining unclear (Taylor et al., 2006; Cho et al., 2008; Firat et al., 2009) .
NO is an important factor in regulating bone metabolism. A large number of studies have shown a close relation between the bone metabolism and the NO level (van't Hof and Ralston, 2001; Brennan et al., 2003; van't Hof et al., 2004) . Low NO concentration is necessary for the maintenance of the normal function of osteoblast and osteoclast. A slightly elevated NO concentration often shows an inhibition for osteoclast, while for the osteoblast it promotes a formation. High NO concentrations inhibit the formation and differentiation of osteoblast and osteoclast (Brennan et al., 2003; van't Hof et al., 2004; Wimalawansa, 2008) . The effect of NO-mediated estrogen on the bone tissue has been extensively studied and confirmed (Wimalawansa, 2008) .
The eNOS isoforms seem to play a key role in regulating osteoblast activity and bone formation since eNOS knockout mice have osteoporosis due to defective bone formation (Aguirre et al., 2001; Armour et al., 2001) . Studies have indicated that the NO derived from the eNOS pathway acts as a mediator of the oestrogen effects on bone (van't Hof and . eNOS also mediates the effects of mechanical loading on the skeleton where it acts along with prostaglandins to promote bone formation and suppress bone resorption (van't Hof and . The previous studies found that eNOS gene polymorphisms can change the activity of eNOS protein, thereby changing the NO concentration in tissues, and NO can impact the trabecular bone volume and structure by influencing the function of osteoclast and osteoblast (van't Hof and Ralston, 2001; Grassi et al., 2006) . Few studies on the relationships between polymorphisms of eNOS gene and osteoporosis have been reported (Taylor et al., 2006; Cho et al., 2008; Firat et al., 2009) . The study by Taylor et al.(2006) failed to demonstrate an association between the eNOS polymorphism, Glu298Asp, and osteoporotic fracture and BMD, while they found a relatively weak association between the eNOS genotypes and hip fracture. Also, Cho et al.(2008) investigated 18 polymorphisms including Glu298Asp and found that the Glu298Asp polymorphism was not associated with BMD. Firat et al.(2009) suggested that eNOS gene polymorphisms, T-786C and Glu298Asp, were not major contributors to adult BMD in the postmenopausal Turkish women. In the present study, through literature reviews we chose two polymorphism loci of the closest relationship between the eNOS and other diseases as the detection sites, which were located at the eNOS gene exon 7 G894T mutation and intron 4 27 bp-VNTR loci (Aguirre et al., 2001; Cho et al., 2008) . We performed clinical testing to examine the associated biochemical markers. The results show that the two eNOS gene polymorphisms affected the BMD of various body parts, and that the average BMD of T/T genotype from the femur neck, ward's triangle and lumbar vertebrae increased significantly, and the average BMD of a/a genotype of the femoral neck was significantly higher than that of b/b genotype. But there was no correlation between the gene polymorphism and plasma NO. This suggests that the concentration of plasma NO did not fully reflect the local bone tissue. Activities of iNOS and cNOS also influence blood NO concentration (van't Hof and .
Our study indicates that the women with genotypes of eNOS G894T G/T have significantly higher plasma concentrations of testosterone and osteocalcin. It is generally believed that androgen may be related to the osteoblast differentiation (Alexandre, 2005) . Testosterone is the most active androgen in women, and with the decrease of testosterone levels, the direct effect of androgen on maintaining bone quality will be lowered (Tok et al., 2004) . Almost all circulating osteocalcin is produced by osteoblasts; therefore, the concentration of blood osteocalcin may specifically reflect the activity of osteoblasts (Lee et al., 2000) . The increases of testosterone and osteocalcin should reflect the activation of osteoblasts, enhancement of bone turnover, and increase of BMD. However, we observed that the BMD in women with G/T genotype was significantly lower than that in those with T/T genotype. The relationship between G894T polymorphism and osteoporosis may be complicated and influenced by other uncertain factors.
Our results also show that the blood concentration of estradiol increased significantly in women with eNOS 27 bp-VNTR a/a genotype. The ovary function of postmenopausal women declines gradually with the decrease of estrogen level. However, the deficiency of estrogen, as a very important risk factor, leads to increasing bone absorption and affects the formation of extracellular matrix and the deposition of calcium salt (Gambacciani and Vacca, 2004; Riggs et al., 2003) . The women with a/a genotype increased blood estradiol and had significant enhancement of local BMD. In addition, the frequency of a allele in normal women was significantly higher than that in osteopenia and osteoporosis women, suggesting that a/a genotype or a allele of eNOS 27 bp-VNTR locus may protect the women from osteoporosis. The protective effects may result from influencing estrogen level or interaction between estrogen and NO. The haplotype analysis in our study showed that G-b was an osteoporosis risk factor, and G-a a protective factor.
Taken together, the present study shows that eNOS G894T G/T genotype influences the plasma testosterone and osteocalcin concentrations, and T/T genotype influences BMD. The a/a genotype and a allele of eNOS 27 bp-VNTR may have protective effects on osteoporosis through influencing estrogen level and interaction of estrogen with NO. The findings provide a useful reference for early clinical intervention and prevention of osteoporosis.
